Common stock, 0.001 par value, authorized 500,000,000 shares issued 9,119,742 and 8,834,613 shares at june 30, 2026 and december 31, 2025, respectively and outstanding, 9,119,004 and 8,833,875 shares at june 30, 2026 and december 31, 2025, respectively
9
9
9
9
Additional paid-in capital
581,030
580,787
580,243
579,812
Treasury stock, at cost 738 shares at june 30, 2026 and december 31, 2025
708
708
708
708
Accumulated deficit
-572,070
-569,141
-564,652
-561,698
Accumulated other comprehensive loss
-17
-21
-37
-42
Total lisata therapeutics, inc. stockholders' equity
8,244
10,926
14,855
17,373
Non-controlling interests
-254
-254
-254
-254
Total equity
7,990
10,672
14,601
17,119
Total liabilities, non-controlling interests and stockholders' equity
11,027
14,059
17,744
21,759
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.